COMMUNIQUÉS West-GlobeNewswire

Share buy-back week 32/2019
12/08/2019
Announcement 12 August 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Aino Health interim report January-June 2019
12/08/2019
12 August 2019 Aino Health interim report January-June 2019 - Increased net sales, improved profit, net sales and cash flow, the business model is showing results April–June 2019 • Net sales increased by 18 percent to [...]
In July revenues increased by 14%, significant growth in all the main markets
12/08/2019
JSC Olainfarm preliminary consolidated results for July 2019 indicate that revenues increased by 14% compared to the same month last year and reached 9.5 million euro. At the same time consolidated results for the first [...]
Notice of Nexstim Plc's Half-Yearly Report H1 2019
12/08/2019
Company announcement, Helsinki, 12 August 2019 at 9.00 am (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), the targeted neuromodulation company developing and marketing pioneering navigated [...]
Curetis Retains H.C. Wainwright & Co. as Strategic Advisor
12/08/2019
Investment bank supports Curetis in assessment of all strategic and tactical financing options Publication of H1-2019 financials postponed to September 18, 2019 Key financials show EUR 7.8 million cash as of June 30, [...]
Abeona Therapeutics annonce ses résultats financiers et mises à jour du deuxième trimestre 2019
10/08/2019
• Cinq patients atteints de la MPS IIIB traités dans le cadre de l'étude Transpher B sur la thérapie génique ABO-101 • Des résultats intermédiaires positifs sur la MPS IIIA ont montré une conservation du développement [...]
AgraFlora Organics Announces Issuance of Securities Pursuant to Debt Settlements
10/08/2019
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
AgraFlora Organics International Inc. annonce son intention de lancer une offre publique visant l’achat d’Eviana Health Corporation
10/08/2019
L’offre évaluée à 0,50 $ CA par action d’Eviana représente une prime de 49,25% par rapport au prix de clôture d’Eviana le 9 août 2019 VANCOUVER, Colombie-Britannique, 09 août 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics [...]
AgraFlora Organics International Inc. Announces Intention to Launch Takeover Bid for Eviana Health Corporation
09/08/2019
Offer valued at C$0.50 per Eviana share 49.25% premium to Eviana’s closing price on August 9, 2019 VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or [...]
InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency
09/08/2019
TEL AVIV, Israel, Aug. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
09/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and [...]
Abeona Therapeutics Reports Second Quarter 2019 Financial Results and Business Updates
09/08/2019
Five patients with MPS IIIB treated in the Transpher B Study of ABO-101 gene therapy Positive interim MPS IIIA data showed preservation of neurocognitive development in youngest patients with robust and sustained [...]
Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Fortress Biotech Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Stemline Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today [...]
Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case
09/08/2019
Sandoz to appeal court ruling to United States Court of Appeals for the Federal Circuit Ruling prevents launch of important, affordable treatment option for US patients affected by chronic autoimmune and inflammatory [...]
Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019
09/08/2019
Loughborough, England, Aug. 09, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and [...]
Generex News Alert: Generex to Announce Positive Shareholder News on Monday August 12, 2019 at 8 AM Payment Details for the 1:1 GNBT Stock Dividend
09/08/2019
Dividend to be Paid to show Appreciation to our Shareholders MIRAMAR, Fla., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) (“Generex”) today provided a news alert [...]
CORRECTION: PROJECT HOPE CALLS FOR CONTINUED FOREIGN AID AMIDST GLOBAL CRISES THREATENING LIVES AND LIVELIHOODS
09/08/2019
90 humanitarian and development organizations urge the U.S. administration to reconsider freezing funds for U.S. foreign assistance programs Millwood, Virginia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- The global health and [...]

Pages